Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT02054858
Eligibility Criteria:
Inclusion Criteria:
* All medical and surgical in-patients aged 40-yrs or over scheduled to undergo contrast-enhanced CT scans.
* Patients willing to give full informed consent for participation
Exclusion Criteria:
* Pregnancy
* Significant upper limb peripheral arterial disease
* Previous history of upper limb deep vein thrombosis
* Patients on glibenclamide or nicorandil (these medications may interfere with RIPC)
* Patients with an estimated pre-operative glomerular filtration rate \<30mls/min/1.73m2
* Patients with a known history of myocarditis, pericarditis or amyloidosis
* Patients who have received intravenous contrast in the previous year
* Patients with severe hepatic disease defined as a an international normalised ratio \>2 in the absence of systemic anticoagulation
* Patients previously enrolled in the trial representing a further scan
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02054858
Study Brief:
Protocol Section:
NCT02054858